Volume : IV, Issue : II, February - 2015

A study of Anti–diabetic Medicine and future scope of its market in India

Pushpendra Singh, Dr. Sanjay Shankar Mishra

Abstract :

Objective: To study the present scenario of diabetic market in India and future scope of business development of companies operating in this segment. Design: The present study is an observational, cross-sectional study. Setting and Participants: 120 doctors, 300 patients, 75 wholesalers/Stockiest and 150 Retailers from 15 cities of India. Methods A predesigned questionnaires containing multiple choice questions were given to doctors, wholesalers/ stockiest and retailers to get the market shares in terms of prescriptions and rupee value for different ands. Statistical analysis: The result of the study was tabulated and statistically analyzed in terms of percentage and their order. Results: Amongst 120 doctors, 71 were diabetologist, 22 were general physician and 27 were nephrologists. Diabetologists see 48.70% patients of diabetes mellitus whereas general nephrologists see 29.60% and physician see 35.90% of diabetic patients. The ratio of type 2 to type 1 DM seen by these doctors is 2.541, 2.677 and 15.2 by diabetologists, nephrologists and general physician respectively. On studying prescribing habit by doctor and availability of drugs the order of preference was Glimepiride and Metformin combination followed by Metformin and then Glimepiride and least for glargine monotherapy. Conclusion: Most of the type 1 DM patients are taking their treatment from diabetologists. Combination therapy of Glimepiride + Metformin is most widely used drugs to treat type 2 diabetes. There is a gap in demand and supply of insulin.

Keywords :

Article: Download PDF   DOI : 10.36106/ijsr  

Cite This Article:

Pushpendra singh, Dr.Sanjay Shankar Mishra A study of Anti-diabetic Medicine and future scope of its market in India International Journal of Scientific Research, Vol : 4, Issue : 2 February 2015

Number of Downloads : 871

References :